Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 30 of 53

Full-Text Articles in Medicine and Health Sciences

Sacral Neuromodulation Treatment For Urinary Voiding Dysfunctions: Results Of Treatment With The Largest Single-Center Series In A Tertiary Referral Center In Turkey, Mehmet Umut Kütükoğlu, Türker Altuntaş, Bahadir Şahi̇n, Ahmet Rahmi̇ Onur Jan 2023

Sacral Neuromodulation Treatment For Urinary Voiding Dysfunctions: Results Of Treatment With The Largest Single-Center Series In A Tertiary Referral Center In Turkey, Mehmet Umut Kütükoğlu, Türker Altuntaş, Bahadir Şahi̇n, Ahmet Rahmi̇ Onur

Turkish Journal of Medical Sciences

Background/aim: Sacral neuromodulation (SNM) is a minimally invasive treatment that modulates spinal reflexes to regulate bladder, urinary sphincter, and pelvic floor and has successfully been used in the treatment of refractory voiding dysfunctions. The aim of this study was to present our experience with SNM in a tertiary referral center with the largest number of patients and review the safety and efficacy of the procedure. Materials and methods: A total of 42 patients with refractory lower urinary tract symptoms were included into the study. After an initial test period, patients who showed more than 50% improvement in their symptoms underwent …


Evaluation Of Treatment Regimens And Long-Term Clinical Outcomes In Patients With Isoniazid-Resistant Pulmonary Tuberculosis: A 5-Year Follow-Up, Ayşe Feyza Aslan, Medi̇ha Gönenç Ortaköylü, Belma Akbaba Bağci, Sezer Toprak Jan 2023

Evaluation Of Treatment Regimens And Long-Term Clinical Outcomes In Patients With Isoniazid-Resistant Pulmonary Tuberculosis: A 5-Year Follow-Up, Ayşe Feyza Aslan, Medi̇ha Gönenç Ortaköylü, Belma Akbaba Bağci, Sezer Toprak

Turkish Journal of Medical Sciences

Background/aim: Considering its early bactericidal activity, isoniazid (H) is an important first-line agent in tuberculosis (TB) treatment. The aim of this study was to evaluate the treatment regimens and results of H-resistant pulmonary TB patients. Materials and methods: We retrospectively evaluated treatment regimens and results of 188 H-resistant pulmonary TB patients who were treated in our center between January 2015 and December 2017. Treatment regimens applied were noted and treatment outcomes were recorded. The long-term results were evaluated. Results: Totally 174 (92.6%) of 188 patients with H-resistant pulmonary TB achieved treatment success. Ninety-seven patients (51.6%) were cured and 77 patients …


Remdesivir Treatment For Patients With Moderate To Severe Covid-19, İmran Hasanoğlu, Hati̇ce Rahmet Güner, İlhami̇ Çeli̇k, Fi̇kret Kanat, Ayşe Batirel, Gülçi̇n Telli̇ Di̇zman, Esma Eryilmaz Eren, Di̇lek Yildiz Sevgi̇, İlkay Bozkurt, Kadri̇ye Kart Yaşar, Sevtap Şenoğlu, Esra Kazak, Ridvan Karaali̇, Aysel Kocagül Çeli̇kbaş, Hüsnü Pullukçu Jan 2022

Remdesivir Treatment For Patients With Moderate To Severe Covid-19, İmran Hasanoğlu, Hati̇ce Rahmet Güner, İlhami̇ Çeli̇k, Fi̇kret Kanat, Ayşe Batirel, Gülçi̇n Telli̇ Di̇zman, Esma Eryilmaz Eren, Di̇lek Yildiz Sevgi̇, İlkay Bozkurt, Kadri̇ye Kart Yaşar, Sevtap Şenoğlu, Esra Kazak, Ridvan Karaali̇, Aysel Kocagül Çeli̇kbaş, Hüsnü Pullukçu

Turkish Journal of Medical Sciences

Background/aim: Remdesivir, which was first developed for the treatment of Ebola disease but failed to meet expectations, has become hope in the fight against the COVID-19 pandemic. This study aimed to evaluate risk factors for mortality and prognosis of adult moderate/severe COVID-19 patients treated with remdesivir, and safety and tolerability of 5 days of remdesivir treatment. Materials and methods: This multicenter prospective observational study was conducted in 14 centers in Turkey. Pregnancy or breastfeeding, multiorgan failure, or usage of vasopressors for septic shock, ALT > 5 × the upper limit of the normal range, or eGRF


Efficacy Of Transcranial Magnetic Stimulation In Treatment-Resistant Depression, Kemal Akpinar, Nalan Kalkan Oğuzhanoğlu, Tuğçe Toker Uğurlu Jan 2022

Efficacy Of Transcranial Magnetic Stimulation In Treatment-Resistant Depression, Kemal Akpinar, Nalan Kalkan Oğuzhanoğlu, Tuğçe Toker Uğurlu

Turkish Journal of Medical Sciences

Background/aim: The use of Transcranial Magnetic Stimulation (TMS) in the add-on treatment of patients with treatment-resistant depression (TRD) is becoming more common. This study aims to investigate the efficacy of TMS on depression and accompanying anxiety symptoms among patients with TRD. Materials and methods: The current study was conducted with 38 patients diagnosed with TRD. The patients were randomly divided into two groups and received 20 sessions of high-frequency (10Hz) TMS and 20 sessions of sham TMS to the left dorsolateral prefrontal cortex in a double-blind and cross-over fashion without a change in their pharmacotherapy. In the clinical evaluation, Hamilton …


Factors Affecting Patient-Acceptable Symptom States And Treatment Decision In Familial Mediterranean Fever, Derya Yildirim, İbrahi̇m Vasi̇, Erdi̇ Tahta, Riza Can Kardaş, Burcugül Özkiziltaş, Hami̇t Küçük, Mehmet Aki̇f Öztürk, Şemi̇nur Haznedaroğlu, Berna Göker, Abdurrahman Tufan Jan 2022

Factors Affecting Patient-Acceptable Symptom States And Treatment Decision In Familial Mediterranean Fever, Derya Yildirim, İbrahi̇m Vasi̇, Erdi̇ Tahta, Riza Can Kardaş, Burcugül Özkiziltaş, Hami̇t Küçük, Mehmet Aki̇f Öztürk, Şemi̇nur Haznedaroğlu, Berna Göker, Abdurrahman Tufan

Turkish Journal of Medical Sciences

Background/aim: Familial Mediterranean fever [FMF] is the most common autoinflammatory disease characterized by inflammatory attacks of fever and polyserositis. Patients' quality of life is significantly affected due to recurrent excruciating pain attacks and complications. This study is performed to evaluate the parameters most affecting patients' satisfaction from treatment. Materials and methods: Three hundred and forty-six consecutive patients diagnosed with FMF were enrolled in this study. Current treatment, acute phase proteins, number, type, and severity of predominant attacks, absenteeism from work/school in the last three months were recorded, and the participants were asked whether they needed additional treatment to evaluate Patient …


Clinically Mild Encephalitis/Encephalopathy With A Reversible Splenial Lesion Of Thecorpus Callosum In Childhood: A Single-Center Experience, Hali̇l Çeli̇k, Betül Emi̇ne Deri̇nkuyu, Erhan Aksoy, Ülkühan Öztoprak, Nesri̇n Ceylan, Ebru Azapağasi, Suna Özdem, Melahat Melek Oğuz, Deni̇z Yüksel Jan 2022

Clinically Mild Encephalitis/Encephalopathy With A Reversible Splenial Lesion Of Thecorpus Callosum In Childhood: A Single-Center Experience, Hali̇l Çeli̇k, Betül Emi̇ne Deri̇nkuyu, Erhan Aksoy, Ülkühan Öztoprak, Nesri̇n Ceylan, Ebru Azapağasi, Suna Özdem, Melahat Melek Oğuz, Deni̇z Yüksel

Turkish Journal of Medical Sciences

Background/aim: Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a rare clinicoradiological syndrome that typically presents with central nervous system symptoms such as loss of consciousness, seizure, headache, and ophthalmoparesis. Materials and methods: Here, we highlight the characteristics of this syndrome together with the clinical and MRI findings of 6 pediatric patients with MERS. Results: Between January 2017 and October 2020, 6 patients with MERS (3 boys and 3 girls) presented to our center. The mean age was 122 ± 54.6 (min-max: 44-180) months. None of the patients had a chronic disease. In our study, infectious agents were detected …


Immune Dysfunction In Covid-19 And Judicious Use Of Antirheumatic Drugs For Thetreatment Of Hyperinflammation, Abdurrahman Tufan, Marco Matucci-Cerinic Jan 2021

Immune Dysfunction In Covid-19 And Judicious Use Of Antirheumatic Drugs For Thetreatment Of Hyperinflammation, Abdurrahman Tufan, Marco Matucci-Cerinic

Turkish Journal of Medical Sciences

: In the Wuhan province of China, almost two years ago, in December 2019, the novel Coronavirus 2019 has caused a severe involvement of the lower respiratory tract leading to an acute life-threatening respiratory syndrome, coronavirus disease-19 (COVID-19). Subsequently, coronavirus 2 (SARS-CoV-2) rapidly spread to the entire world causing a pandemic and affected every single person on earth either directly or indirectly with destroying all facets of social life and economy. Since the announcement of COVID-19 as a global pandemic, we have witnessed tremendous scientific work on all aspects of COVID-19 across the globe, which has never been witnessed before. …


Evaluation Of Efficacy And Safety Of Pirfenidone 200 Mg Tablets In Patients With Idiopathicpulmonary Fibrosis In A Real-Life Setting, Necmi̇ye Funda Coşkun, Aykut Çi̇lli̇, İsmai̇l Hanta, Can Sevi̇nç, Ayşe Ödemi̇ş, Ahmet Ursavaş Jan 2021

Evaluation Of Efficacy And Safety Of Pirfenidone 200 Mg Tablets In Patients With Idiopathicpulmonary Fibrosis In A Real-Life Setting, Necmi̇ye Funda Coşkun, Aykut Çi̇lli̇, İsmai̇l Hanta, Can Sevi̇nç, Ayşe Ödemi̇ş, Ahmet Ursavaş

Turkish Journal of Medical Sciences

Background/aim: Phase III trials have demonstrated a significant efficacy and an acceptable safety for pirfenidone in patients having mild to moderate idiopathic pulmonary fibrosis (IPF). Real-life data on the use of pirfenidone 200 mg tablets are limited. This study aimed to investigate the efficacy and safety of pirfenidone 200 mg tablets for the treatment of IPF in a real-life setting. Materials and methods: A retrospective, multicenter study conducted in four university hospitals in Turkey between January 2017 and January 2019. Clinical records of patients diagnosed with mild to moderate IPF and receiving pirfenidone (200 mg tablets, total 2400 mg/day) were …


An Update Of Anti-Viral Treatment Of Covid-19, Serap Yavuz, Feri̇de İpek Komsuoğlu Çeli̇kyurt Jan 2021

An Update Of Anti-Viral Treatment Of Covid-19, Serap Yavuz, Feri̇de İpek Komsuoğlu Çeli̇kyurt

Turkish Journal of Medical Sciences

Background/aim: Currently there is not an effective antiviral treatment for COVID-19, but a large number of drugs have been evaluated since the beginning of the pandemic, and many of them have been used for the treatment of COVID-19 despite the preliminary or conflicting results of the clinical trials. We aimed to review and summarize all of the current knowledge on the antivirals for COVID-19. Results: There are 2 main drug groups for SARS-CoV-2: agents that target proteins or RNA of the virus or interfere with proteins or biological processes in the host that support the virus. The main drug groups …


Hydroxychloroquine Plus Azithromycin And Early Hospital Admission Are Beneficial Incovid-19 Patients: Turkish Experience With Real-Life Data, Eli̇f Tanriverdi̇, Mustafa Çörtük, Bi̇nnaz Zeynep Yildirim, Efsun Gonca Uğur Chousein, Demet Turan, Hali̇t Çinarka, Mehmet Aki̇f Özgül, Erdoğan Çeti̇nkaya Jan 2021

Hydroxychloroquine Plus Azithromycin And Early Hospital Admission Are Beneficial Incovid-19 Patients: Turkish Experience With Real-Life Data, Eli̇f Tanriverdi̇, Mustafa Çörtük, Bi̇nnaz Zeynep Yildirim, Efsun Gonca Uğur Chousein, Demet Turan, Hali̇t Çinarka, Mehmet Aki̇f Özgül, Erdoğan Çeti̇nkaya

Turkish Journal of Medical Sciences

Background/aim: New treatment regimens for COVID-19, which has threatened the world recently, continue to be investigated. Although some of the treatments are promising, it is thought to be early to state that there is definitive treatment. Experiences and treatment protocol studies from treatment centers are still important. The aim of this study is to evaluate factors affecting the treatment process of the first cases followed in our clinic. Materials and methods: The consecutive hospitalized patients with COVID-19 pneumonia were analyzed in this retrospective and cross-sectional study. Data were recorded from the electronic and written files of patients. Results: Eighty-three patients …


The Prognostic Value Of Serum Levels Of A Proliferation-Inducing Ligand (April) Intreatment-Naïve Patients With Chronic Lymphocytic Leukemia, Si̇nem Ni̇hal Esatoğlu, Di̇lek Keski̇n, Ahmet Emre Eşkazan, Tuğrul Elverdi̇, Ayşe Sali̇hoğlu, Muhli̇s Cem Ar, Şeni̇z Öngören, Zafer Başlar, Yildiz Aydin, Hafi̇ze Uzun, Teoman Soysal Jan 2021

The Prognostic Value Of Serum Levels Of A Proliferation-Inducing Ligand (April) Intreatment-Naïve Patients With Chronic Lymphocytic Leukemia, Si̇nem Ni̇hal Esatoğlu, Di̇lek Keski̇n, Ahmet Emre Eşkazan, Tuğrul Elverdi̇, Ayşe Sali̇hoğlu, Muhli̇s Cem Ar, Şeni̇z Öngören, Zafer Başlar, Yildiz Aydin, Hafi̇ze Uzun, Teoman Soysal

Turkish Journal of Medical Sciences

Background/aim: A proliferation-inducing ligand (APRIL) has been investigated as a prognostic marker in chronic lymphocytic leukemia (CLL) patients. However, there is no cut-off level for serum APRIL (sAPRIL) levels that predict time to treatment in CLL patients. Materials and methods: Between May and December 2012, 94 consecutive CLL patients and 25 healthy controls were assessed. sAPRIL levels were measured by ELISA. Demographic data and prognostic markers were obtained from the patients' files. Treatment-naïve patients were followed up for 6.5 years for any treatment need. Results: Patients were divided into 3 groups: Treatment-naïve (n = 47), chemotherapy receiving (n = 25), …


Covid-19 Scientific Publications From Turkey, Rafi̇ye Çi̇ftçi̇ler, İbrahi̇m Celaletti̇n Haznedaroğlu, Abdurrahman Tufan, Mehmet Aki̇f Öztürk Jan 2021

Covid-19 Scientific Publications From Turkey, Rafi̇ye Çi̇ftçi̇ler, İbrahi̇m Celaletti̇n Haznedaroğlu, Abdurrahman Tufan, Mehmet Aki̇f Öztürk

Turkish Journal of Medical Sciences

No abstract provided.


Efficacy And Safety Of Ruxolitinib In Patients With Myelofibrosis: A Retrospective Andmulticenter Experience In Turkey, Nur Soyer, Ridvan Ali̇, Mehmet Turgut, İbrahi̇m Celaletti̇n Haznedaroğlu, Asu Fergün Yilmaz, İsmet Aydoğdu, Ali̇ Pi̇r, Volkan Karakuş, Gökhan Özgür, Cem Ki̇s, Funda Ceran, Gül İlhan, Melda Özkan, Müzeyyen Aslaner, İdri̇s İnce Jan 2021

Efficacy And Safety Of Ruxolitinib In Patients With Myelofibrosis: A Retrospective Andmulticenter Experience In Turkey, Nur Soyer, Ridvan Ali̇, Mehmet Turgut, İbrahi̇m Celaletti̇n Haznedaroğlu, Asu Fergün Yilmaz, İsmet Aydoğdu, Ali̇ Pi̇r, Volkan Karakuş, Gökhan Özgür, Cem Ki̇s, Funda Ceran, Gül İlhan, Melda Özkan, Müzeyyen Aslaner, İdri̇s İnce

Turkish Journal of Medical Sciences

Background/aim: The aim of this study is to assess the efficacy and safety of ruxolitinib in patients with myelofibrosis. Materials and methods: From 15 centers, 176 patients (53.4% male, 46.6% female) were retrospectively evaluated. Results: The median age at ruxolitinib initiation was 62 (28-87) and 100 (56.8%) of all were diagnosed as PMF. Constitutional symptoms were observed in 84.7%. The median initiation dose of ruxolitinib was 30 mg (10-40). Dose change was made in 69 (39.2%) patients. Forty seven (35.6%) and 20 (15.2%) of 132 patients had hematological and nonhematological adverse events, respectively. The mean spleen sizes before and after …


Effects Of Hydroxychloroquine And Favipiravir On Clinical Course In Outpatients Withcovid-19, Seyda Kayhan Ömeroğlu, Fehmi̇naz Temel, Di̇lek Altun, Mehmet Burak Öztop Jan 2021

Effects Of Hydroxychloroquine And Favipiravir On Clinical Course In Outpatients Withcovid-19, Seyda Kayhan Ömeroğlu, Fehmi̇naz Temel, Di̇lek Altun, Mehmet Burak Öztop

Turkish Journal of Medical Sciences

Background/aim: Due to the importance of early outpatient treatment to prevent hospitalization and disease progression, we examined the effects of hydroxychloroquine and favipiravir, which were initiated in early period, on the clinical course of COVID-19 outpatients. Materials and methods: Data of confirmed COVID-19 outpatients over a 4-month period were analyzed retrospectively. Public Health Management System (HSYS) was used for the case-based follow-up. Patients on antiviral therapy for at least five days, including hydroxychloroquine and / or favipiravir and patients who were followed-up for 30 days were included in this analysis. Results: We enrolled 1489 patients in this study. Overall, 775 …


Retrospective Evaluation Of Seven Different Treatment Protocols In Hospitalizedcovid-19 Patients, Kübra Demi̇r Önder, Ayşegül Seremet Keski̇n, Hande Berk Cam, Derya Seyman, Nefi̇se Öztoprak Çuvalci Jan 2021

Retrospective Evaluation Of Seven Different Treatment Protocols In Hospitalizedcovid-19 Patients, Kübra Demi̇r Önder, Ayşegül Seremet Keski̇n, Hande Berk Cam, Derya Seyman, Nefi̇se Öztoprak Çuvalci

Turkish Journal of Medical Sciences

Background/aim: As the experience has increased regarding SARS-CoV-2 in time, treatment trends have changed since the beginning of the pandemic. This study aimed to compare the outcomes of different treatment modalities for inpatients in a tertiary pandemic hospital in Antalya, Turkey. Materials and methods: Individuals aged 18 years and above who tested positive for SARS-CoV-2 in PCR with presenting COVIDrelated radiological findings, hospitalized for at least 3 days, and completed follow-up between March 15, 2020 and November 30, 2020 were included in the study. Patients' data were reviewed retrospectively. Seven treatment groups based on the single or combined use of …


Covid-19, Immune System Response, Hyperinflammation And Repurposingantirheumatic Drugs, Abdurrahman Tufan, Aslihan Avanoğlu Güler, Marco Matucci-Cerinic Jan 2020

Covid-19, Immune System Response, Hyperinflammation And Repurposingantirheumatic Drugs, Abdurrahman Tufan, Aslihan Avanoğlu Güler, Marco Matucci-Cerinic

Turkish Journal of Medical Sciences

In the Wuhan Province of China, in December 2019, the novel coronavirus 2019 (COVID-19) has caused a severe involvement of the lower respiratory tract leading to an acute respiratory syndrome. Subsequently, coronavirus 2 (SARS-CoV-2) provoked a pandemic which is considered a life-threatening disease. The SARS-CoV-2, a family member of betacoronaviruses, possesses singlestranded positive-sense RNA with typical structural proteins, involving the envelope, membrane, nucleocapsid and spike proteins that are responsible for the viral infectivity, and nonstructural proteins. The effectual host immune response including innate and adaptive immunity against SARS-Cov-2 seems crucial to control and resolve the viral infection. However, the severity …


Igg4-Related Disease: A Contemporary Review, Hazan Karadeni̇z, Augusto Vaglio Jan 2020

Igg4-Related Disease: A Contemporary Review, Hazan Karadeni̇z, Augusto Vaglio

Turkish Journal of Medical Sciences

Background/aim: Immunoglobulin G4-related disease (IgG4-RD), is an immune-mediated fibroinflammatory condition, which may involve multiple organs and mostly presents with high serum IgG4 levels and specific histopathological characteristics. As IgG4-RD is a relatively new entity the etiology, prevalence and epidemiologic knowledge is quite limited. Although involvement of almost all anatomical regions has been reported, the most commonly affected regions are pancreas, lacrimal glands, salivary glands, retroperitoneum, orbita, lymph nodes, kidney and lungs. Diagnosis is made with combined evaluation of clinical, radiological and histopathological findings. Typical histopathological features include storiform fibrosis, dense lymphoplasmacytic infiltrates and obliterative phlebitis. Its course is typically marked …


Familial Mediterranean Fever, From Pathogenesis To Treatment: A Contemporary Review, Abdurrahman Tufan, Helen Lachmann Jan 2020

Familial Mediterranean Fever, From Pathogenesis To Treatment: A Contemporary Review, Abdurrahman Tufan, Helen Lachmann

Turkish Journal of Medical Sciences

Familial Mediterranean fever (FMF) (OMIM #249100) is the most common hereditary autoinflammatory disease in the world. FMF is caused by gain of function mutations of MEFV gene which encodes an immune regulatory protein, pyrin. Over the last few years, we have witnessed several new developments in the pathogenesis, genetic testing, diagnosis, comorbidities, disease related damage and treatment approaches to FMF. Elucidation of some of the pathogenic mechanisms has led to the discovery of pathways involved in inflammatory, metabolic, cardiovascular and degenerative diseases. The use of next generation sequencing in FMF has revealed many new gene variants whose clinical significance may …


A Novel Urethra Compression Technique Using Turkish Continence Device For Male Urinary Incontinence, Öner Odabaş, İrem Gül Sancak, Yusuf Kasap, Zerri̇n Mahmut, Erkan Ölçücüoğlu, Sedat Taştemur, Nesli̇han İnci̇ Zengi̇n Jan 2020

A Novel Urethra Compression Technique Using Turkish Continence Device For Male Urinary Incontinence, Öner Odabaş, İrem Gül Sancak, Yusuf Kasap, Zerri̇n Mahmut, Erkan Ölçücüoğlu, Sedat Taştemur, Nesli̇han İnci̇ Zengi̇n

Turkish Journal of Medical Sciences

Background/aim: The male sling operation and artificial urinary sphincter implantation are common methods for treating urinary incontinence. However, there are some drawbacks to these methods such as infection, urethral erosion, pain, inefficiency, and the technical difficulty of the operations. Here we describe a new device we have named the Turkish Continence Device (TCD) which has advantages over these other methods. The aim of this study was perform experiments with the TCD prototype in vivo and ex vivo to determine efficiency, convenience of implantation, and negative effects.Materials and methods: We implanted the prototype device in male goats and sheep, compressing the …


Treatment Of Idiopathic Granulomatous Mastitis And Factors Related With Disease Recurrence, Emre Tekgöz, Seda Çolak, Muhammet Çinar, Sedat Yilmaz Jan 2020

Treatment Of Idiopathic Granulomatous Mastitis And Factors Related With Disease Recurrence, Emre Tekgöz, Seda Çolak, Muhammet Çinar, Sedat Yilmaz

Turkish Journal of Medical Sciences

Background/aim: Idiopathic granulomatous mastitis is a rare, benign inflammatory disease of breast. There is no general agreement on the appropriate treatment choice.The aim of the study was to investigate the immunosuppressive administer for idiopathic granulomatous mastitis and risk factors related with disease recurrence.Materials and methods: The data of 53 patients with idiopathic granulomatous mastitis were evaluated for this cross-sectional retrospective study. Demographic features and clinical characteristics and course of the patients were obtained from file records. Results: The mean age of the patients was 37.2 ± 6.6 years. Fifty-one of 53 patients received immunosuppressive treatment with or without surgery. Forty-seven …


Posthepatectomy Liver Failure, İlhan Ocak, Serdar Topaloğlu, Koray Acarli Jan 2020

Posthepatectomy Liver Failure, İlhan Ocak, Serdar Topaloğlu, Koray Acarli

Turkish Journal of Medical Sciences

Liver surgery is one of the most complex surgical interventions with high risk and potential for complications. Posthepatectomy liver failure (PHLF) is a serious complication of liver surgery that occurs in about 10% of patients undergoing major liver surgery. It is the main source of morbidity and mortality. Appropriate surgical techniques and intensive care management are important in preventing PHLF. Early start of the liver support systems is very important for the PHLF patient to recover, survive, or be ready for a liver transplant. Nonbiological and biological liver support systems should be used in PHLF to prepare for treatment or …


Childhood Atopic Dermatitis: Current Developments, Treatment Approaches, And Future Expectations, Pinar Gür Çeti̇nkaya, Ümi̇t Murat Şahi̇ner Jan 2019

Childhood Atopic Dermatitis: Current Developments, Treatment Approaches, And Future Expectations, Pinar Gür Çeti̇nkaya, Ümi̇t Murat Şahi̇ner

Turkish Journal of Medical Sciences

Atopic dermatitis (AD) is the most common chronic inflammatory skin disorder of childhood. Underlying factors that contribute to AD are impaired epithelial barrier, alterations in the lipid composition of the skin, immunological imbalance including increased Th2/Th1 ratio, proinflammatory cytokines, decreased T regulatory cells, genetic mutations, and epigenetic alterations. Atopic dermatitis is a multifactorial disease with a particularly complicated pathophysiology. Discoveries to date may be considered the tip of the iceberg, and the increasing number of studies in this field indicate that there are many points to be elucidated in AD pathophysiology. In this review, we aimed to illustrate the current …


Serum Prolidase Level In Patients With Brucellosis And Its Possible Relationship With Pathogenesis Of The Disease: A Prospective Observational Study, Oğuzhan Sitki Di̇zdar, Ayşe Turunç Özdemi̇r, Osman Başpinar, Derya Koçer, Yavuz Katircilar, İlhami̇ Çeli̇k Jan 2019

Serum Prolidase Level In Patients With Brucellosis And Its Possible Relationship With Pathogenesis Of The Disease: A Prospective Observational Study, Oğuzhan Sitki Di̇zdar, Ayşe Turunç Özdemi̇r, Osman Başpinar, Derya Koçer, Yavuz Katircilar, İlhami̇ Çeli̇k

Turkish Journal of Medical Sciences

Background/aim: Changes in collagen metabolism and fibroblastic activity may play a role in the pathogenesis of brucellosis. The prolidase enzyme plays an important role in collagen synthesis. We aimed to investigate the association of prolidase levels with brucellosis.Materials and methods: Serum prolidase levels in 20 patients newly diagnosed with brucellosis were compared with levels in 30 healthy control subjects. Patients with brucellosis were reassessed 3 months later for prolidase, other laboratory measurements, and response to treatment. Results: The levels of serum prolidase were significantly higher in brucellosis patients compared with those of healthy controls. Prolidase, sedimentation, and C-reactive protein levels …


Polycythemia Vera: Diagnosis, Clinical Course, And Current Management, Yahya Büyükaşik, Ridvan Ali̇, Muhli̇s Cem Ar, Mehmet Turgut, Aki̇f Seli̇m Yavuz, Güray Saydam Jan 2018

Polycythemia Vera: Diagnosis, Clinical Course, And Current Management, Yahya Büyükaşik, Ridvan Ali̇, Muhli̇s Cem Ar, Mehmet Turgut, Aki̇f Seli̇m Yavuz, Güray Saydam

Turkish Journal of Medical Sciences

Very important developments related to polycythemia vera (PV) have occurred during the last two decades. The discovery of Janus kinase (JAK) 2 mutations has changed both the diagnosis and clinical management of PV. Currently JAK2 molecular testing is essential in the diagnostic work-up and JAK2 mutation positivity is a major diagnostic criterion. The discovery of JAK2 mutations suggested that abnormal JAK-STAT signaling was a pivotal feature in the pathogenesis of Philadelphia-negative myeloproliferative neoplasms. This idea led to the development of JAK inhibitors. Currently ruxolitinib, a JAK1/JAK2 inhibitor, is also approved for PV patients with hydroxyurea resistance or intolerance. International collaborations …


Cyclosporine-A For Severe Childhood Atopic Dermatitis: Clinical Experience On Efficacyand Safety Profile, Hayri̇ye Saricaoğlu, Serkan Yazi̇ci̇, Özge Zorlu, Emel Bülbül Başkan, Kenan Aydoğan Jan 2018

Cyclosporine-A For Severe Childhood Atopic Dermatitis: Clinical Experience On Efficacyand Safety Profile, Hayri̇ye Saricaoğlu, Serkan Yazi̇ci̇, Özge Zorlu, Emel Bülbül Başkan, Kenan Aydoğan

Turkish Journal of Medical Sciences

Background/aim: Management of atopic dermatitis (AD) in children is still challenging. The aim of this study was to evaluate the efficacy and safety profile of cyclosporine-A (CsA) treatment in children with severe and recalcitrant AD. Materials and methods: Medical records of 43 children followed between January 2010 and December 2015 and treated with systemic CsA were evaluated retrospectively. Treatment efficacy was assessed according to the physician's global assessment (PGA) score. According to the treatment response, patients were grouped as nonresponder, moderate responder, or good responder. Effects of the variables on treatment response were evaluated by analysis of variance (ANOVA). The …


The Efficacy Of Microphototherapy With A Medlight Cupcubegrimed Device In Psoriatic Patients With Localized Lesions, Nesli̇han Yildirim, Gül Erki̇n Jan 2017

The Efficacy Of Microphototherapy With A Medlight Cupcubegrimed Device In Psoriatic Patients With Localized Lesions, Nesli̇han Yildirim, Gül Erki̇n

Turkish Journal of Medical Sciences

Background/aim: Psoriasis is a chronic skin disease. To reduce side effects associated with current treatment modalities, new treatment methods are required. Some clinicians have begun to use microphototherapy to treat psoriatic patients with a limited number of lesions (lesions affecting <10% of the body surface area). Materials and methods: Microphototherapy is indicated in patients whose lesions persist despite systemic and topical treatment or when such treatment is contraindicated. Our study aimed to evaluate the efficacy of microphototherapy in psoriasis patients with localized lesions. Patients in this unblinded and prospective study were treated three times a week for 50 sessions using a MedLight CupCUBE Grimed microphototherapy device that emits an ultraviolet B (UVB) spectrum. Results: Forty-five lesions in 23 psoriatic patients were treated. Treatment outcome was evaluated based on the Psoriasis Severity Index (PSI). PSI scores decreased significantly during the treatment. Conclusion: The MedLight CupCUBE Grimed microphototherapy device was effective for the treatment of psoriasis patients with localized lesions. The device can administer UVB radiation to involved regions while protecting uninvolved regions and minimizing radiation dose. However, having to be administered by experienced technicians and the long time required for each treatment session are disadvantages of the technique.


A Review Of Pediatric Pulmonary Hypertension With New Guidelines, Serdar Kula, Ayhan Pektaş Jan 2017

A Review Of Pediatric Pulmonary Hypertension With New Guidelines, Serdar Kula, Ayhan Pektaş

Turkish Journal of Medical Sciences

This study aims to review pediatric pulmonary hypertension (PH) by comparing the guidelines of the European Society of Cardiology (ESC)/European Respiratory Society (ERS), the American Heart Association (AHA)/American Thoracic Society (ATS), and the European Pediatric Pulmonary Vascular Disease Network (EPPVDN). All three sets of guidelines define PH as having a mean pulmonary artery pressure of ≥25 mmHg and accept the validity of the World Health Organization (WHO) classification system. Every child with a high index of suspicion for PH should undergo an initial work-up of chest X-rays, electrocardiography, and echocardiography. The AHA/ATS guidelines emphasize the necessity of cardiac catheterization and …


Epidemiology And Analysis Of Invasive Fungal Infections In Patients Withhematological Malignancies: A Single-Center Real-Life Experience, Nur Soyer, Hati̇ce Demet Ki̇per Ünal, Fi̇li̇z Vural, Fahri̇ Şahi̇n, Mahmut Töbü, Ayhan Dönmez, Murat Tombuloğlu, Bi̇lgi̇n Arda, Güray Saydam Jan 2017

Epidemiology And Analysis Of Invasive Fungal Infections In Patients Withhematological Malignancies: A Single-Center Real-Life Experience, Nur Soyer, Hati̇ce Demet Ki̇per Ünal, Fi̇li̇z Vural, Fahri̇ Şahi̇n, Mahmut Töbü, Ayhan Dönmez, Murat Tombuloğlu, Bi̇lgi̇n Arda, Güray Saydam

Turkish Journal of Medical Sciences

Background/aim: Invasive fungal infection (IFI) causes morbidity and mortality among patients with hematological malignancies. We evaluated the incidence and treatment characteristics of IFIs between October 2012 and December 2013. Materials and methods: Patients who received chemotherapy or stem cell transplantation were retrospectively evaluated. Fungal infections were classified according to EORTC criteria.Results: Prophylaxis and antifungal therapy were given in 30.5% and 23.6% of 522 chemotherapy courses, respectively. The incidence of proven/probable IFI was 6.7%. The incidence of IFI among patients who received prophylaxis was significantly higher than among those who did not receive it (11.3% vs. 4.6%, P = 0.005). There …


How To Manage Pseudoangiomatous Stromal Hyperplasia: Our Clinical Experience, Emi̇ne Kurt, Sevi̇m Turanli, Fatma Markoç, Ali̇ Uğur Berberoğlu Jan 2017

How To Manage Pseudoangiomatous Stromal Hyperplasia: Our Clinical Experience, Emi̇ne Kurt, Sevi̇m Turanli, Fatma Markoç, Ali̇ Uğur Berberoğlu

Turkish Journal of Medical Sciences

Background/aim: Pseudoangiomatous stromal hyperplasia (PASH) is a rare and benign mesenchymal proliferative breast lesion. Our aim is to review the clinical and radiological features of PASH and define a standard approach for its diagnosis and management. Materials and methods: Clinical records of 35 consecutive patients with PASH were retrospectively reviewed between 2009 and 2015. Patients with clinically or radiologically detected mass and patients who underwent biopsy for other indications and were diagnosed incidentally were included in the study. Results: There were 34 female patients and one male patient with gynecomastia. Twenty-three patients had palpable masses, and 16 of them were …


Eleven Patients With Primary Thyroid Lymphoma: A Single Center Experience, Hasan Bostanci, Kürşat Di̇kmen, Nalan Akyürek, Ahmet Çağri Büyükkasap, Aydin Yavuz, Mehmet Muhi̇tti̇n Yalçin, Murat Akin Jan 2017

Eleven Patients With Primary Thyroid Lymphoma: A Single Center Experience, Hasan Bostanci, Kürşat Di̇kmen, Nalan Akyürek, Ahmet Çağri Büyükkasap, Aydin Yavuz, Mehmet Muhi̇tti̇n Yalçin, Murat Akin

Turkish Journal of Medical Sciences

Background/aim: Primary thyroid lymphoma (PTL) is a very rare thyroid malignancy. It should be diagnosed and treated immediately and accurately. Our aim was to evaluate the diagnostic methods and treatment results for patients with PTL.Materials and methods: We retrospectively evaluated the records of 11 patients with PTL from 2009 to 2015, diagnosed at our institute. Age, sex, stage, histopathologic type, presence of Hashimoto's thyroiditis, diagnostic methods, treatment types, and recurrence were examined.Results: Six patients were female, 5 were male, and the median age of the patients was 61 years (range: 15-76 years). All patients had a large palpable mass in …